Pancreatic Cancer Research

ResearcherFreeman HospitalActive in the last 2 years

Steven Alan White

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9948-1075; OpenAlex author ID A5114626355. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
65
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 14

  1. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. Co-author DOI 10.1001/jamanetworkopen.2024.17625↗
  2. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  3. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Co-author DOI 10.1245/s10434-022-13054-2↗
  4. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population… First author DOI 10.1245/s10434-021-09823-0↗
  5. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarc… Last author DOI 10.1016/j.hpb.2019.12.001↗
  6. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin defini… Co-author DOI 10.1016/j.pan.2020.01.004↗
  7. Calcium channel blockers in pancreatic cancer: increased overall survival in a retrospective cohort study. Last author DOI 10.1097/cad.0000000000000947↗
  8. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. Last author DOI 10.1002/jso.25209↗
  9. Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer. Co-author DOI 10.1002/bjs.10580↗
  10. The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biocel.2016.03.009↗
  11. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection for Pancreatic Cancer Study Group. Co-author DOI 10.1016/j.ejso.2015.08.158↗
  12. Arrested development and the great escape--the role of cellular senescence in pancreatic cancer. First author DOI 10.1016/j.biocel.2014.10.018↗
  13. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. Co-author DOI 10.1016/j.jamcollsurg.2013.11.017↗
  14. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.ejso.2011.12.020↗

Closest collaborators

The 25 strongest of 65 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sivesh Kathir Kamarajah · 3 shared papers, 2020–2023 · strength 0.43
  2. John A. G. Moir · 3 shared papers, 2014–2020 · strength 0.34
  3. Derek Manas · 3 shared papers, 2012–2020 · strength 0.29
  4. Samuel James Tingle · 2 shared papers, 2018–2020 · strength 0.27
  5. Giuseppe Fusai · 4 shared papers, 2014–2023 · strength 0.24
  6. Mohammad Abu Hilal · 4 shared papers, 2014–2023 · strength 0.24
  7. Stuart Michael Robinson · 3 shared papers, 2012–2020 · strength 0.22
  8. Richard Charnley · 3 shared papers, 2012–2020 · strength 0.22
  9. Fadi S. Dahdaleh · 1 shared paper, 2021 · strength 0.17
  10. Samer A. Naffouje · 1 shared paper, 2021 · strength 0.17
  11. George I. Salti · 1 shared paper, 2021 · strength 0.17
  12. Jelena Mann · 2 shared papers, 2014–2016 · strength 0.15
  13. Wasfi Alrawashdeh · 1 shared paper, 2020 · strength 0.15
  14. James Bundred · 1 shared paper, 2020 · strength 0.15
  15. Beate Haugk · 2 shared papers, 2012–2020 · strength 0.14
  16. Charles J. Imber · 3 shared papers, 2014–2017 · strength 0.13
  17. R. Ravikumar · 3 shared papers, 2014–2017 · strength 0.13
  18. Stephen J. Wigmore · 3 shared papers, 2014–2017 · strength 0.13
  19. Laleh Golkar Melstrom · 1 shared paper, 2023 · strength 0.13
  20. Fabio Ausania · 1 shared paper, 2023 · strength 0.13
  21. Riccardo Memeo · 1 shared paper, 2023 · strength 0.13
  22. John B. Martinie · 1 shared paper, 2023 · strength 0.13
  23. Yuman Fong · 1 shared paper, 2023 · strength 0.13
  24. Dianrong Xiu · 1 shared paper, 2023 · strength 0.13
  25. Carolina González Abós · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.